Pharmaceutical grade heparin heparin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cells, Cultured Cell Line Blood Platelets Endothelium, Vascular Mast Cells CHO Cells Extracellular Matrix Muscle, Smooth, Vascular Liver

Organisms8

Cattle Swine Flavobacterium Rabbits Cricetinae Dogs Capparaceae Rats, Sprague-Dawley

Diseases33

Hemorrhage Thrombophlebitis Thrombosis Thrombocytopenia Thromboembolism Venous Thrombosis Pulmonary Embolism Recurrence Disseminated Intravascular Coagulation Mast-Cell Sarcoma Myocardial Infarction Venous Thromboembolism Angina, Unstable Antithrombin III Deficiency Postoperative Complications Postoperative Hemorrhage Astrocytoma Coronary Thrombosis Acute Disease Brain Neoplasms Breast Neoplasms Glioma Neoplasm Recurrence, Local Disease Progression Adenocarcinoma Blood Coagulation Disorders Neoplasm Metastasis Sagittal Sinus Thrombosis Thrombophilia Disease Models, Animal Phlebitis Blood Loss, Surgical Antiphospholipid Syndrome

Chemicals and Drugs119

Heparin, Low-Molecular-Weight Heparin Antagonists Heparin Lyase Heparin Cofactor II Anticoagulants Antithrombin III Antithrombins Glycosaminoglycans Enoxaparin Dalteparin Dermatan Sulfate Protamines Factor Xa Platelet Factor 4 Hirudins Thrombin Fibrinolytic Agents Polysaccharide-Lyases Heparinoids Chondroitin Sulfates Oligosaccharides Disaccharides Recombinant Proteins Pentosan Sulfuric Polyester Polysaccharides Sulfates Pipecolic Acids Iduronic Acid Fibroblast Growth Factor 1 Antithrombin Proteins Sulfuric Acids Sepharose Peptide Fragments Factor X Fibrinopeptide A Lipoprotein Lipase Serine Proteinase Inhibitors Aspirin Platelet Aggregation Inhibitors Fibroblast Growth Factor 2 Uronic Acids Fibrin Tissue Plasminogen Activator Nitrous Acid Streptokinase Warfarin Prothrombin Sulfotransferases Blood Coagulation Factors Platelet Glycoprotein GPIIb-IIIa Complex Fibrinogen Chymases Hexadimethrine Bromide Chlorates Fibronectins Dextrans Polymers Antibodies, Monoclonal Protease Nexins Citric Acid Receptors, Fibroblast Growth Factor Factor IXa Dextran Sulfate Thromboplastin Glycoproteins Antibodies Fibroblast Growth Factors Factor XIa Fibrin Fibrinogen Degradation Products Laminin Complement C1 Inhibitor Protein Sulfuric Acid Esters Serpins Chondroitin Citrates Thrombospondins Collagen Serine Endopeptidases Fat Emulsions, Intravenous Immunoglobulin Fab Fragments Blood Proteins Glucuronidase Calcium Peptides Ancrod Lipase Acenocoumarol Coated Materials, Biocompatible Protease Inhibitors Chondroitinases and Chondroitin Lyases DEAE-Cellulose Hyaluronic Acid Periodic Acid RNA, Messenger Receptors, Cell Surface Sulfatases Edetic Acid Antineoplastic Agents Amino Acids, Diamino Tumor Markers, Biological Growth Substances Sodium Chloride p-Dimethylaminoazobenzene Oligopeptides Tryptases P-Selectin Fibrinolysin Inositol 1,4,5-Trisphosphate Protein C Carrier Proteins Casein Kinases Fibrin Tissue Adhesive Glucosamine Cathepsin G Drug Combinations Sulfur Radioisotopes Phosphoadenosine Phosphosulfate Lipoproteins Urokinase-Type Plasminogen Activator

Analytical, Diagnostic and Therapeutic Techniques and Equipment57

Partial Thromboplastin Time Whole Blood Coagulation Time Blood Coagulation Tests Chromatography, Affinity Hirudin Therapy Thrombin Time Treatment Outcome Injections, Subcutaneous Infusions, Intravenous Prospective Studies Retrospective Studies Chromatography, Gel Binding, Competitive Surface Plasmon Resonance Thrombolytic Therapy Drug Therapy, Combination Prognosis Neoplasm Grading Follow-Up Studies Injections, Intravenous Electrophoresis, Polyacrylamide Gel Prothrombin Time Neoplasm Staging Survival Analysis Chromatography, High Pressure Liquid Magnetic Resonance Spectroscopy Models, Molecular Double-Blind Method Antineoplastic Combined Chemotherapy Protocols Survival Rate Immunohistochemistry Angioplasty, Balloon, Coronary Bleeding Time Risk Factors Administration, Oral Chemical Fractionation Disease-Free Survival Blood Specimen Collection Thrombelastography Platelet Count Chromatography, Ion Exchange Combined Modality Therapy Catheters, Indwelling Cardiopulmonary Bypass Infusions, Parenteral Electrophoresis, Paper Catheterization, Central Venous Renal Dialysis Kaplan-Meier Estimate Severity of Illness Index Enzyme-Linked Immunosorbent Assay Disease Models, Animal Chromatography Drug Administration Schedule Risk Assessment Extracorporeal Circulation Spectrometry, Fluorescence

Phenomena and Processes31

Partial Thromboplastin Time Whole Blood Coagulation Time Blood Coagulation Protein Binding Thrombin Time Binding Sites Kinetics Dose-Response Relationship, Drug Time Factors Amino Acid Sequence Carbohydrate Sequence Molecular Weight Binding, Competitive Structure-Activity Relationship Carbohydrate Conformation Cell Division Prothrombin Time Platelet Aggregation Cell Adhesion Hemostasis Protein Conformation Platelet Activation Bleeding Time Substrate Specificity Platelet Count Hydrogen-Ion Concentration Protein Structure, Tertiary Osmolar Concentration Base Sequence Mutation Vascular Patency

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture3

Hexadimethrine Bromide Polymers Coated Materials, Biocompatible

Information Science5

Molecular Sequence Data Amino Acid Sequence Carbohydrate Sequence Survival Rate Base Sequence

Health Care13

Treatment Outcome Drug Contamination Prospective Studies Retrospective Studies Follow-Up Studies Survival Analysis Double-Blind Method Survival Rate Risk Factors Disease-Free Survival Kaplan-Meier Estimate Severity of Illness Index Risk Assessment

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Heparin, Low-Molecular-Weight Heparin Antagonists Heparin Lyase Heparin Cofactor II Anticoagulants Antithrombin III Antithrombins Partial Thromboplastin Time Glycosaminoglycans Enoxaparin Whole Blood Coagulation Time Dalteparin Dermatan Sulfate Protamines Factor Xa Platelet Factor 4 Hirudins Thrombin Fibrinolytic Agents Blood Coagulation Polysaccharide-Lyases Hemorrhage Thrombophlebitis Thrombosis Blood Coagulation Tests Chromatography, Affinity Hirudin Therapy Heparinoids Chondroitin Sulfates Oligosaccharides Protein Binding Thrombocytopenia Thrombin Time Binding Sites Treatment Outcome Disaccharides Kinetics Thromboembolism Recombinant Proteins Pentosan Sulfuric Polyester Venous Thrombosis Molecular Sequence Data Dose-Response Relationship, Drug Polysaccharides Pulmonary Embolism Sulfates Time Factors Pipecolic Acids Injections, Subcutaneous Cattle Infusions, Intravenous Amino Acid Sequence Iduronic Acid Fibroblast Growth Factor 1 Antithrombin Proteins Carbohydrate Sequence Sulfuric Acids Swine Sepharose Molecular Weight Peptide Fragments Factor X Cells, Cultured Fibrinopeptide A Lipoprotein Lipase Serine Proteinase Inhibitors Aspirin Flavobacterium Drug Contamination Platelet Aggregation Inhibitors Fibroblast Growth Factor 2 Uronic Acids Prospective Studies Recurrence Fibrin Tissue Plasminogen Activator Retrospective Studies Chromatography, Gel Nitrous Acid Streptokinase Warfarin Prothrombin Binding, Competitive Surface Plasmon Resonance Sulfotransferases Disseminated Intravascular Coagulation Blood Coagulation Factors Platelet Glycoprotein GPIIb-IIIa Complex Fibrinogen Thrombolytic Therapy Structure-Activity Relationship Drug Therapy, Combination Mast-Cell Sarcoma Chymases Myocardial Infarction Prognosis Cell Line Venous Thromboembolism Carbohydrate Conformation Neoplasm Grading

No FAQ available that match "pharmaceutical grade heparin heparin"